API Market to reach a USD 839.1 Billion by 2033
Source: Yahoo Finance The global demand for pharmaceutical products, including both branded and generic drugs, has been steadily rising. As a result, the need for active pharmaceutical ingredients, which are the essential components of these medications, has grown substantially. New York, Jan. 23, 2024 (GLOBE NEWSWIRE) — According to Market.us, the global Active Pharmaceutical Ingredient market size […]
Asia-Pacific Pharma Logistics Market to Reach $197 Billion by 2028
Source: Yahoo Finance Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) — The “Asia-Pacific Pharmaceutical Logistics Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to ResearchAndMarkets.com’s offering. The Asia-Pacific pharmaceutical logistics market is experiencing robust growth with a projected Compound Annual Growth Rate (CAGR) of 6.68% from 2023 to 2028. A deep-dive […]
Generative AI in the pharmaceutical industry: Moving from hype to reality
Source: mckinsey.com The technology could offer pharma companies a once-in-a-century opportunity – but only if they learn to scale it and address the industry’s unique challenges. Accelerated drug discovery. More efficient clinical trials. Quicker regulatory approvals. Ultra targeted marketing and medical materials generated in-house. Generative AI is transforming nearly all aspects of the pharmaceutical industry, revamping […]
Overhaul in pharma manufacturing: India imposes stringent quality controls.
Source: Business Line Concerns raised by health authorities and non-compliance with international standards have prompted this push, with large companies given a six-month deadline and smaller ones a 12-month timeframe to comply. India has tightened rules to ensure mandatory compliance with good manufacturing practices – which looks at bringing in quality control on materials, machines, […]
Implementing revised Schedule M rules uphill task for small pharma
Source: Business Standard A notification of the revised Schedule M rules by the Ministry of Health and Family Welfare has elicited mixed responses from the pharma sector and industry observers. While the industry has welcomed the revision of rules, several analysts said that implementation and compliance can become a challenge for smaller pharmaceutical companies. The […]
What Is Aspartame? Here Is All That You Need To Know About It
Source: News18 The term ‘aspartame’ has taken over the internet recently and how. It has been discovered that this element which is rather injurious to human health is actually present in a lot of our favourite food and beverage element. While everybody has a lot of opinions about it, very few know in detail about […]
The story of a drug that India has failed to ban
Source: Scroll The Centre banned the sale of Deanxit, a contested psychiatric drug approved without clinical data. But 10 years on, it continues to be sold by other companies. In 2009, an article in Monthly Index of Medical Specialities drew attention to a psychiatric drug from Denmark being sold in the Indian market. In the article, the […]
‘Upgrade Quality or Risk Shutdowns’, DCGI
Source: News18 India’s pharmaceutical industry has undergone a comprehensive regulatory overhaul spearheaded by the nation’s apex health regulatory agency and its chief, the Drug Controller General of India (DCGI), amid quality concerns raised by global regulators. Throughout the year, DCGI Rajeev Singh Raghuvanshi made headlines for his several moves, ranging from aggressive raids on pharmaceutical […]
The 10 Biggest Trends Revolutionizing Healthcare In 2024
Source: Forbes A longer-living population, the emergence of transformative technologies with applications across the healthcare spectrum, and continued global economic uncertainty. These are the key societal drivers that will impact healthcare in 2024. Their convergence means we are heading into uncharted waters. On the technology side, artificial intelligence (AI) promises to dramatically change everything from […]
Cell, gene therapy to rule pharmaceutical sector in 2024: Report
Source: Mid Day The report by GlobalData, a data and analytics company, is based on a survey of 115 healthcare industry professionals. It revealed that 18 per cent of industry professionals were convinced that CGT will dominate as the most important trend in pharma next year. This was followed by personalised/precision medicine (16 per cent). […]